Carson Advisory’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,620
Closed -$558K 188
2024
Q3
$558K Buy
3,620
+520
+17% +$78.8K 0.35% 78
2024
Q2
$452K Buy
3,100
+5
+0.2% +$717 0.32% 84
2024
Q1
$457K Buy
3,095
+40
+1% +$5.74K 0.32% 88
2023
Q4
$417K Buy
3,055
+4
+0.1% +$520 0.32% 87
2023
Q3
$393K Buy
3,051
+9
+0.3% +$1.2K 0.34% 87
2023
Q2
$404K Sell
3,042
-64
-2% -$8.44K 0.34% 86
2023
Q1
$402K Buy
3,106
+1,335
+75% +$174K 0.36% 82
2022
Q4
$241K Buy
1,771
+102
+6% +$13.5K 0.23% 108
2022
Q3
$202K Buy
1,669
+3
+0.2% +$386 0.22% 117
2022
Q2
$214K Buy
+1,666
New +$218K 0.24% 107

Other funds holding XLV

Carson Advisory's XLV Position: Q4 2024 in Review

Carson Advisory sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2024, closing a stake of 3,620 shares — an estimated $558K sold.

Carson Advisory first reported a position in XLV in Q2 2022 and held it in 10 quarters. The position peaked at $558K in Q3 2024. 1,759 funds tracked by Wall St. Rank hold XLV as of Q4 2024.

  • Carson Advisory reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2024 after selling out during the quarter.
  • Carson Advisory sold 3,620 State Street Health Care Select Sector SPDR ETF shares in Q4 2024, an estimated $558K.
  • Carson Advisory first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2022 and held it in 10 quarters.
  • Carson Advisory's State Street Health Care Select Sector SPDR ETF position peaked at $558K in Q3 2024.
  • 1,759 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2024.

Based on Carson Advisory's 13F filing for Q4 2024, filed 13 Feb 2025.